Cell MedX Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMXC research report →
Price Chart
About the company
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain.
- CEO
- David M. Jeffs
- IPO
- 2013
- HQ
- Carson City, NV, US
Get TickerSpark's AI analysis on CMXC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $126.33M
- P/E
- -4.66
- PEG
- 0.06
- P/S
- 0.00
- P/B
- -2.24
- EV/EBITDA
- -15.72
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 60.42%
- ROIC
- 185.43%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $0
- Net Income
- $-566,293-297.4%
- EPS
- $-0.03-782.4%
- OCF Growth
- +2.9%
- FCF Growth
- +2.9%
- 52W High
- $0.42
- 52W Low
- $0.42
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.75
- Avg Volume
- 0
No earnings-call transcripts are available for CMXC yet.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 6, 22 | HARGREAVES BRADLEY S | sell | 10,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CMXC coverage
Recent articles, reports, and earnings notes.
No research on CMXC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CMXC report →StimCell Energetics Inc. (Formerly "Cell MedX Corp.") Announces Major Corporate Updates and Rebranding
accesswire.com · Nov 4
Cell MedX Corp. Closes Private Placement Financing
newsfilecorp.com · Mar 19
Cell MedX Corp. Announces Resignation of Director
newsfilecorp.com · Feb 28
Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board
newsfilecorp.com · Feb 26
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
newsfilecorp.com · Dec 19
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
newsfilecorp.com · Nov 27
Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer
newsfilecorp.com · Nov 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.